Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin

Journal of Surgical Oncology

Volumn 97, Issue 7, 2008, Pages 615-620

  Kyung, Dong Son ^a   Kim, Tae Jung ^a   Youn, Soo Lee ^a,c   Gyeong, Sin Park ^a   Ki, Taik Han ^a,c   Jin, Soo Lim ^b   Chang, Suk Kang ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c NONE   (South Korea)

Author keywords

Basal cell carcinoma; CD44v6; Depth of invasion; Differentiation; MMP 1; Squamous cell carcinoma; Tissue array block

Indexed keywords

CD44V6 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERSTITIAL COLLAGENASE; KI 67 ANTIGEN; PROTEIN P53; STROMELYSIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER GRADING; CANCER INVASION; COMPARATIVE STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

EID: 44849123594     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21006     Document Type: Article

References (31)

1. Korean Ministry of Health, Welfare: 2002 Annual Report of the Korea Central Cancer Registry, Seoul, 2003, p 93.
2. David EE, Rosalie E, Bernett LJ, et al.: Lever's histopathology of the skin. 9th edition. Philadelphia: Lippincott Williams & Wilkins; 2004; pp 830-837.
3. Rubel JR, Milford EL, Abdi R: Cutaneous neoplasms in renal tranplant recipients. Eur J Dermatol 2002;12:532-535.
4. Dzubow LM: Metastatic basal cell carcinoma originating in the supra-parotid region. J Dermatol Surg Oncol 1986;12:1306-1308.
5. Healy E, Angus B, Lawrence CM, et al.: Prognostic value of Ki67 antigen expression in basal cell carcinomas. Br J Dermatol 1995;133:737-741.
6. Yerebakan O, Ciftcioglu MA, Akkaya BK, et al.: Prognostic value of Ki-67, CD31 and epidermal growth factor receptor expression in basal cell carcinoma. J Dermatol 2003;30:33-41.
7. Dingemans KP, Ramkema MD, Koopman G, et al.: The expression of CD 44 glycoprotein adhesion molecules in basal cell carcinomas is related to growth pattern and invasiveness. Br J Dermatol 1999;140:17-25.
8. Kooy AJ, Tank B, de Jong AA, et al.: Expression of E-cadherin, alpha- & beta-catenin, and CD44v6 and the subcellular localization of E-cadherin and CD44v6 in normal epidermis and basal cell carcinoma. Human Pathol 1999;30:1328-1335.
9. Dazard JE, Augias D, Neel H, et al.: MDM-2 protein is expressed in different layers of normal human skin. Oncogene 1997;14:1123-1128.
10. Kerkela E, Ala-aho R, Lohi J, et al.: Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J cancer 2001;84:659-669.
11. Friedman HI, Cooper PH, Wanebo HJ: Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 1985;56:1099-1105.
12. Jacobs GH, Rippey JJ, Altini M: Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982;49:533-537.
13. Rudzki Z, Jothy S: CD44 and the adhesion of neoplastic cells. Mol Pathol 1997;50:57-71.
14. Yang S, Yueh KC: Hyaluronate binding assay study of transfected CD44 v4-v7 isoforms into the human gastric carcinoma cell line Sc-Mi. J Pathol 1998;184:291-296.
15. Liotta LA, Steeg PS, Steler-stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-336.
16. Flug M, Kopf-Maier P: The basement membrane and its involvement in carcinoma cell invasion. Acta Anat 1995;152:69-84.
17. Mauviel A: Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993;53:288-295.
18. Matrisian LM, Mcdonnell S, Miller DB, et al.: The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 1991;302:157-162.
19. Gray ST, Wilkins RJ, Yun K: Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol 1992;141:301-306.
20. Tsukifuji R, Sakai T, Hatamochi A, et al.: Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase. Histochem J 1997;29:1-7.
21. Bramhall SR, Stamp GW, Dunn J, et al.: Expression of collagenase(MMP2), stromelysin(MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer 1996;73:972-978.
22. Heppner KJ, Martrisian LM, Jensen RA, et al.: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor inducer host response. Am J Pathol 1996;149:273-282.
23. Majmudar G, Nelson BR, Jensen TC, et al.: Increased expression of matrix metallopreteinase-3(stromelysin) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome. Mol Carcinog 1994;11:29-33.
24. Okada A, Bellocq JP, Rouyer N, et al.: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Med Sci 1995;92:2730-2734.
25. Tsukifuji R, Tagawa K, Hatamochi A, et al.: Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis. Br J Cancer 1999;80:1087-1091.
26. Bourrguignon LY, Iida N, Zhu D, et al.: Involvement of CD44 and its variant isoforms in membrane cytoskeleton interaction, cell adhesion and tumor metastasis. J Neurooncol 1995;26930:201-208.
27. Takeuchi K, Yamaguchi A, Urano T, et al.: Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res 1995;86:292-297.
28. Naot D, Sionov RV, Shalom DI: CD44 structure, function, and association with the malignant process. Adv Cancer Res 1997;71:241-319.
29. Sy Ms, Mori H, Liu D: CD44 as a marker in human cancers. Curr Opin Oncol 1997;9:108-112.
30. Koyama S, Maruyama T, Adachi S: Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: A two-color flow-cytometric analysis. J Cancer Res Clin Oncol 1999;125:47-54.
31. Kajita M, Itoh Y, Chiba T, et al.: Membrane type-1 MMP cleaves CD44 and promotes cell migration. J Cell Biol 2001;153:893-904.